Immutep Limited (ASX:IMM)
0.395
+0.015 (3.95%)
At close: Mar 6, 2026
Immutep Market Cap
Immutep has a market cap or net worth of 582.12 million as of March 6, 2026. Its market cap has increased by 31.12% in one year.
Market Cap
582.12M
Enterprise Value
484.20M
Revenue
7.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 582.12M, an increase of 15,792.05%. That is a compound annual growth rate of 18.72%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 510.04M |
| Opthea | 738.77M |
| Racura Oncology | 446.99M |
| Clarity Pharmaceuticals | 1.33B |
| Dimerix | 243.16M |
| Orthocell | 240.11M |
| PYC Therapeutics | 1.46B |
| Neuren Pharmaceuticals | 1.56B |